Stryker Corporation (SYK)
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
Stryker's 13.6% three-month rally reflects stronger sales, margins and production, but execution risks and a premium peer valuation could test further gains.
Stryker Q2 Earnings Call Highlights
Stryker NYSE: SYK reported 9% organic sales growth in the second quarter of 2026 and adjusted earnings per share growth of 17.9%, as the medical technology company continued recovering from a cybersecurity incident that disrupted operations earlier in the year.
SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery
Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.
Stryker Corporation (SYK) Q2 2026 Earnings Call Transcript
Stryker Corporation (SYK) Q2 2026 Earnings Call Transcript
Stryker (SYK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates
Stryker (SYK) came out with quarterly earnings of $3.69 per share, beating the Zacks Consensus Estimate of $3.46 per share. This compares to earnings of $3.13 per share a year ago.
Stryker beats quarterly estimates on strong demand for medical devices
U.S. medical device maker Stryker on Thursday beat Wall Street estimates for second-quarter results, aided by strong demand for its implants and devices used in complex procedures ranging from spinal to orthopedic surgeries.
Stryker Logs Higher Profit, Revenue Amid Cyberattack Recovery
The medical technology company reported a profit of $1.28 billion and and said it has made progress in recovering from a March cyberattack.
Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Stryker's Q2 Results Likely to Reflect Recovery of Q1 Deferred Orders
SYK heads into Q2 with robotic surgery momentum, deferred revenue recovery and strong procedure demand as investors watch for earnings and margin trends.
Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio
SYK launches Mako RPS, expanding into handheld robotics for total knee replacement and broadening access to robotic-assisted orthopedic procedures.
